The first-ever guideline from Endocrine Society on Addison's disease details specifics of diagnostic tests and glucocorticoid therapy.
The analysis led to the identification of 4 potentially pathogenic missense variants in CABLES1.
Functional hypothalamic amenorrhea should be diagnosed by exclusion.
The guidelines focused on idiopathic short stature, growth hormone deficiency, and primary IGF-I deficiency.
A case report suggested that combination therapy with growth hormone and anastrozole may improve final height in congenital adrenal hyperplasia.
BACH2 is a major risk locus for Addison's disease, according to a study published in the Journal of Internal Medicine.
In the United Kingdom, rates of the disease were highest for those born in December, while in Poland, rates were highest for those born in January.
Patients with nonfunctional adrenal tumors have a nearly 2-fold increased risk for diabetes.
Updated recommendations from the Endocrine Society revise aldosteronism screening guidelines.
Four-month-old developed iatrogenic Cushing's syndrome after 6 weeks of intranasal dexamethasone ophthalmic solution.
Acute ozone exposure increases stress hormones and causes alterations in peripheral lipid metabolism in humans.
Endocrinology Advisor Articles
- Maternal Deaths in the United States: Sounding a Call to Action
- Semaglutide Improved Beta-Cell Function and Glycemic Control in Type 2 Diabetes
- Blood Glucose Self-Monitoring in Type 2 Diabetes Does Not Benefit Glycemic Control
- Major Cardiovascular Event Incidence in T2D: Degludec vs Glargine
- The Handoff: Your Week in Endocrinology News - 6/23/17
- Reduced Cardiovascular Events in Type 2 Diabetes Treated With Dapagliflozin
- Canagliflozin Reduces Cardiovascular Stress In Older Patients With Type 2 Diabetes
- Diabetic Retinopathy Caused by Sleep Apnea in T2D
- Transition-of-Care Algorithm Performs Well in Surgery Patients With Type 2 Diabetes
- GLP-1 Analog Counteracts Antipsychotic-Induced Glucose Intolerance, Weight Gain